Carys Morgan

688 total citations
19 papers, 346 citations indexed

About

Carys Morgan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Carys Morgan has authored 19 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 6 papers in Oncology. Recurrent topics in Carys Morgan's work include Gastric Cancer Management and Outcomes (10 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Carys Morgan is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Carys Morgan collaborates with scholars based in United Kingdom, United States and France. Carys Morgan's co-authors include Margaret May, Emma E. Vincent, Jeremy M. Tavaré, Douglas J.E. Elder, Joya Pawade, S.A. Roberts, T. Crosby, Muhammad Sohail, Elaine Thomas and M Hetzel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Carys Morgan

18 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carys Morgan United Kingdom 8 148 126 116 80 25 19 346
Shinsuke Tasaki Japan 11 94 0.6× 154 1.2× 103 0.9× 99 1.2× 69 2.8× 30 365
Beilong Zhong China 13 150 1.0× 112 0.9× 99 0.9× 101 1.3× 85 3.4× 28 366
Junjie Hong China 11 82 0.6× 123 1.0× 76 0.7× 50 0.6× 34 1.4× 43 339
Stacey Ward United States 6 125 0.8× 73 0.6× 79 0.7× 73 0.9× 57 2.3× 10 324
Shengfu Huang China 11 79 0.5× 98 0.8× 122 1.1× 86 1.1× 46 1.8× 27 344
Pierre Rivet France 10 164 1.1× 113 0.9× 87 0.8× 63 0.8× 80 3.2× 12 375
Takeshi Namekawa Japan 10 167 1.1× 160 1.3× 116 1.0× 115 1.4× 94 3.8× 18 432
Thomas Hoelting Germany 14 145 1.0× 81 0.6× 130 1.1× 109 1.4× 44 1.8× 21 460
Akira Okimura Japan 8 112 0.8× 82 0.7× 67 0.6× 141 1.8× 49 2.0× 28 290
Dörthe Jechorek Germany 13 126 0.9× 130 1.0× 277 2.4× 63 0.8× 80 3.2× 38 509

Countries citing papers authored by Carys Morgan

Since Specialization
Citations

This map shows the geographic impact of Carys Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carys Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carys Morgan more than expected).

Fields of papers citing papers by Carys Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carys Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carys Morgan. The network helps show where Carys Morgan may publish in the future.

Co-authorship network of co-authors of Carys Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Carys Morgan. A scholar is included among the top collaborators of Carys Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carys Morgan. Carys Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gordon, Anderley, Martin Davidson, Jane Thompson, et al.. (2024). 1424P Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial. Annals of Oncology. 35. S888–S888. 1 indexed citations
2.
3.
4.
Hutchings, Hayley, et al.. (2023). Gastric Radiotherapy in the UK – Current Practice and Opinion on Future Directions. International Journal of Radiation Oncology*Biology*Physics. 117(2). e286–e286. 1 indexed citations
5.
6.
Patel, Bijal, Clare Peckitt, Katharina von Loga, et al.. (2021). Maintenance durvalumab after first-line platinum-based chemotherapy in advanced oesophago-gastric (OG) adenocarcinoma: Results from the PLATFORM trial.. Journal of Clinical Oncology. 39(15_suppl). 4015–4015. 7 indexed citations
7.
Cunningham, David, Clare Peckitt, Gayathri Anandappa, et al.. (2020). Evaluating maintenance therapies in advanced oesophago-gastric adenocarcinoma (OGA): Interim analysis and biomarker results from the PLATFORM study.. Journal of Clinical Oncology. 38(4_suppl). 282–282. 2 indexed citations
8.
Morgan, Carys, et al.. (2019). Developing efficient bioreactor microcarrier cell culture system for large scale production of mesenchymal stem cells (MSCs). Cytotherapy. 21(5). S73–S73. 6 indexed citations
9.
Ajani, Jaffer A., Anghel Adrian Udrea, Tomasz Sarosiek, et al.. (2018). Ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Secondary analysis of efficacy and safety results of 4 dosing regimens in the phase II trial I4T-MC-JVDB.. Journal of Clinical Oncology. 36(4_suppl). 117–117. 1 indexed citations
10.
Ajani, Jaffer A., Anghel Adrian Udrea, Tomasz Sarosiek, et al.. (2017). A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB. Annals of Oncology. 28. v238–v238. 3 indexed citations
11.
Foley, Kieran, Carys Morgan, S.A. Roberts, & T. Crosby. (2017). Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer. Clinical Oncology. 29(11). 760–766. 12 indexed citations
12.
Vincent, Emma E., Douglas J.E. Elder, Linda O′Flaherty, et al.. (2014). Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation. PLoS ONE. 9(12). e114725–e114725. 26 indexed citations
13.
Bulusu, V.R., John Fullarton, Michael Leahy, et al.. (2013). Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours. British Journal of Cancer. 109(6). 1403–1407. 5 indexed citations
14.
Morgan, Carys, Tania Tillett, Jeremy Braybrooke, & Thankamma Ajithkumar. (2011). Management of uncommon chemotherapy-induced emergencies. The Lancet Oncology. 12(8). 806–814. 27 indexed citations
15.
Vincent, Emma E., Douglas J.E. Elder, Elaine Thomas, et al.. (2011). Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. British Journal of Cancer. 104(11). 1755–1761. 157 indexed citations
16.
Morgan, Carys, et al.. (2010). PCN17 CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A UK EPIDEMIOLOGY STUDY. Value in Health. 13(3). A26–A26. 6 indexed citations
17.
Shapiro, Ron, Avik Basu, A. Zeevi, et al.. (2009). Bortezomib rescue in refractory acute humoral rejection--report of a case.. PubMed. 431–2. 3 indexed citations
18.
Button, M., et al.. (2008). Study to Determine Adequate Margins in Radiotherapy Planning for Esophageal Carcinoma by Detailing Patterns of Recurrence After Definitive Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 73(3). 818–823. 70 indexed citations
19.
Morgan, Carys, et al.. (1992). Color flow-guided repair of axillary artery pseudoaneurysm. Journal of Ultrasound in Medicine. 11(11). 625–626. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinsuke Tasaki Breakdown of academic impact, for papers by Beilong Zhong Breakdown of academic impact, for papers by Junjie Hong Breakdown of academic impact, for papers by Stacey Ward Breakdown of academic impact, for papers by Shengfu Huang Breakdown of academic impact, for papers by Pierre Rivet Breakdown of academic impact, for papers by Takeshi Namekawa Breakdown of academic impact, for papers by Thomas Hoelting Breakdown of academic impact, for papers by Akira Okimura Breakdown of academic impact, for papers by Dörthe Jechorek
Rankless by CCL
2026